Since 10% of ME/CFS patients have these alleles, their risk is altered around 1.5-2.0-fold, meaning genetic differences in the immune system may change the risk of developing ME/CFS (89)
Some protocols utilize twice-daily dosing (morning and early afternoon) to maintain more stable effects throughout the day, though once-daily administration appears sufficient for most users based on the sustained metabolic effects of the peptide
Kannan R, Mittur A, Bao Y, Tsuruo T, Kaplowitz N
Type 2 diabetes occurs when the body can no longer effectively use insulin
Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States This article was submitted to Hematologic Malignancies, a section of the journal Frontiers in Oncology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers